DNAswitch Revenue
Biotechnology Research • 
Padua, Veneto, Italy • 1-10 Employees
$
DNAswitch revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at DNAswitch
Anna Maria Gambetta
CEO and co-founder
Company overview
| Headquarters | Padua, Veneto, Italy |
| NAICS | 541714 |
| Founded | 2024 |
| Employees | 1-10 |
About DNAswitch
DNAswitch is a biotech company committed to develop gene therapy treatments tailored at people with Huntington’s disease. Located in Padua, Italy, it was founded by Prof. Graziano Martello and Dr. Anna Maria Gambetta starting from April 2024. This budding spin-off of the University of Padua has backing from Fondazione Golinelli Partners that helps it grow the future of genetic medicine.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Employees by Department
DNAswitch has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
DNAswitch has never raised funding before.
United Kingdom
United States
South Africa
Frequently asked questions
DNAswitch is located in Padua, Veneto, IT.
DNAswitch generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.
DNAswitch has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
DNAswitch was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.
DNAswitch has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
